Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes

American Heart Journal

Volumn 168, Issue 2, 2014, Pages

  Mehta, Rajendra H ^a   Westerhout, Cynthia M ^b   Zheng, Yinggan ^b   Giugliano, Robert P ^c   Huber, Kurt ^d   Prabhakaran, Dorairaj ^e   Harrington, Robert A ^f   Newby, Kristin L ^a   Armstrong, Paul W ^b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d WILHELMINEN HOSPITAL   (Austria)

^e CENTRE FOR CHRONIC DISEASE CONTROL   (India)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE;

ARTICLE; BODY MASS; COMORBIDITY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; OBESITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; ADULT; AGED; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; HAZARD RATIO; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ACUTE CORONARY SYNDROME; AGE FACTORS; AGED; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK ADJUSTMENT; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 84905086136     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.04.009     Document Type: Article

References (26)

1. S.M. Grundy, J.I. Cleeman, and S.R. Daniels et al. Diagnosis and management of metabolic syndrome: an American Heart Association/National Heart Blood and Lung Institute scientific statement Circulation 112 2005 2735 2752
2. D.E. Laaksonen, H.M. Lakka, and L.K. Niskanen et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of metabolic syndrome in prospective cohort study Am J Epidemiol 156 2002 1070 1077
3. M.P. Stern, K. Williams, and C. Gonzalez-Villalpando et al. Does the metabolic syndrome improve the identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27 2004 2676 2681
4. R.S. Lindsay, and B.V. Howard Cardiovascular risk associated with metabolic syndrome Curr Diab Rep 4 2004 63 68
5. S. Mottillo, K.B. Filion, and J. Genest et al. The metabolic syndrome and cardiovascular risk - a systematic review and meta-analysis J Am Coll Cardiol 56 2010 1113 1132
6. A.H.A. Statistical Update: executive summary - Heart Disease and Stroke Statistics - 2012 update. A report from the American Heart Association Circulation 125 2012 188 197
7. T. Dohi, K. Miyauchi, and T. Kasai et al. Impact of metabolic syndrome on 10-year clinical outcomes in patients with acute coronary syndromes Circ J 73 2009 1754 1758
8. C. Boulon, M. Lafitte, and V. Richeboeuf et al. Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significance Am J Cardiol 98 2006 1429 1434
9. G.G. Schwartz, A.G. Olson, and M. Szarek et al. Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome. An Analysis of the Myocardial Infarction Reduction With Aggressive Cholesterol Lowering (MIRACL) trial Diabetes Care 28 2005 2508 2513
10. G. Levantasi, A. Macchia, and R. Marfisi et al. Metabolic syndrome and the risk of cardiovascular events after acute myocardial infarction J Am Coll Cardiol 46 2005 277 283
11. A. Mente, S. Yusuf, and S. Islam et al. Metabolic syndrome and risk of acute myocardial infarction. A case-control study of 26,903 subjects from 52 countries J Am Coll Cardiol 55 2010 2390 2398
12. B.C. Solymoss, M.G. Bourassa, and L. Campeau et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity Am J Cardiol 93 2004 159 164
13. H.M. Lakka, D.E. Laaksonen, and T.A. Lakka et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2002 2709 2716
14. N. Sattar, A. Gaw, and O. Scherbakova et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study Circulation 108 2003 414 419
15. S. Malik, N.D. Wong, and S.S. Franklin et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults Circulation 110 2004 1245 1250
16. J. Stamler, O. Vaccaro, and J.D. Neaton et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial Diabetes Care 16 1993 434 444
17. R.M. Califf, K.S. Pieper, and K.L. Lee et al. Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial Circulation 101 2000 2231 2238
18. K.L. Lee, L.H. Woodlief, and E.J. Topol et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients Circulation 91 1995 1659 1668
19. M.T. Roe, A.R. Halabi, and R.H. Mehta et al. Documented traditional risk factors and mortality in patients with non-ST-elevation myocardial infarction Am Heart J 153 2007 507 514
20. R.H. Mehta, R.M. Califf, and J. Garg et al. The impact of anthropomorphic indices on clinical outcomes in patients with acute ST elevation myocardial infarction Eur Heart J 28 2007 415 424
21. R.H. Mehta, A. Stebbins, and R.D. Lopes et al. Race, bleeding and outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy Am J Med 124 2011 43 57
22. R.P. Giugliano, L.K. Newby, and R.A. Harrington et al. The Early Glycoprotein IIb/IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome - study design and rationale Am Heart J 149 2005 994 1002
23. R.P. Giugliano, J.A. White, and C. Bode et al. EARLY ACS Investigators. Early versus delayed, provisional eptifibatide in acute coronary syndromes N Engl J Med 360 2009 2176 2190
24. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
25. K.G. Alberti, P. Zimmet, and J. Shaw The metabolic syndrome - a new worldwide definition Lancet 366 2005 1059 1062
26. E.M. Antman, M. Cohen, and P.J.L.M. Bernick et al. The TIMI risk score for unstable angina/N-ST elevation MI: a method for prognostification and therapeutic decision making JAMA 284 2000 835 842